10th Anti-Aging Medicine World Congress from 29 to 31 March at the Grimaldi Forum Monaco
In ten years, the Anti-Aging Medicine World Congress (AMWC), which was first established in 2003, has become the most important aesthetic medicine and anti-aging congress in the world.
Its distinctive feature is its global approach to aging, which combines two aspects: the exterior, via aesthetics (dermatology, surgery and medicine), and the interior, via anti-aging medicine.
In 2011, the global market for medical and surgical aesthetics increased by an average of 10.1%, with an estimated turnover of between 3.2 and 3.8 billion euros. It is expected to increase further by 11.2% in 2012 (3.5-4.2 billion euros), despite the slowdown in growth in the market in Europe, which is expected to reduce it to 5% as against 7% in 2011.
Asia, where there are more operations on the nose and eyelids than for breast enlargement, had the lion's share of the market in 2011, with a leap of 15.7%. Spurred on by China and South Korea, this geographic area should see an identical annual average increase between now and 2016, as against growth of barely 7% for Europe and 11% for the United States and Latin America.
In total, between 2012 and 2016, annual growth in the global aesthetic medicine market is expected to reach 11.2%, making it worth between 5.5 and 6.4 billion euros.
There is increased demand for natural, gentler techniques. Surgical operations must be less invasive, with smaller, less obvious scars.
With regard to medicine, anti-wrinkle techniques are often combined, such as using botulinum toxin for the upper part of the face, and hyaluronic acid for the lower part. The techniques are far from being an alternative to surgery; they can be used in preparation for surgery or to maintain the results of surgery.
In 2012, it is also necessary to focus on the issue of the safety of implanted materials, the equipment used and the products that are injected.